Relevance of biologic markers in colorectal carcinoma: A comparative study of a broad panel

Cancer

Volumn 94, Issue 3, 2002, Pages 647-657

  Barozzi, Chiara ^a   Ravaioli, Matteo ^a   D'Errico, Antonia ^a   Grazi, Gian Luca ^a   Poggioli, Gilberto ^a   Cavrini, Giulia ^a   Mazziotti, Alighieri ^a   Grigioni, Walter Franco ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Biologic markers; Colorectal carcinoma; Insulin like growth factor II; Liver metastasis; Logistic regression; Matrix metalloproteinase 2; Transforming growth factor

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE A; NEU DIFFERENTIATION FACTOR; ONCOPROTEIN; SOMATOMEDIN B; TRANSFORMING GROWTH FACTOR ALPHA; VASCULOTROPIN;

ADULT; AGE; ANGIOGENESIS; ARTICLE; CANCER GRADING; CANCER STAGING; CHI SQUARE DISTRIBUTION; COLORECTAL CARCINOMA; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; TUMOR CLASSIFICATION;

ADULT; AGED; CARCINOMA; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; DNA, COMPLEMENTARY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INSULIN-LIKE GROWTH FACTOR II; LIVER NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR MARKERS, BIOLOGICAL;

EID: 0036469151     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10278     Document Type: Article

References (66)

1. Surgical treatment of liver metastases in patients with colorectal cancer
2. Cancer statistics, 2000
3. Management of hepatic metastases
4. Surgical resection of colorectal carcinoma metastases to the liver
5. Determinants of survival following hepatic resection for metastatic colorectal cancer
6. Eleven years of experience in the surgical therapy of the liver metastases from colorectal tumors
7. Prognostic value of pathologic characteristics of colorectal cancer
8. Pathologic prognostic factors for gastrointestinal cancer
9. Carcinomas of the colon and rectum: A comparison of staging
10. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer. Analysis of 1001 consecutive cases
11. Resection of colorectal liver metastases: 25-Year experience
12. Polypeptide growth factors: Roles in normal and abnormal cell growth
13. Epidermal growth factor and transforming growth factor α
14. Association of epidermal growth factor-related peptides and type 1 receptor tyrosine kinase receptors with prognosis of human colorectal carcinomas
15. Clinical relevance of transforming growth factor α, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors
16. Role and new perspectives of transforming growth factor-α (TGF-α) in adenocarcinoma of the gastroesophageal junction
17. Expression of growth factors and their receptors in human early colorectal carcinomas: Immunohistochemical study
18. EGF, TGF-α and EGF-R in human colorectal adenocarcinoma
19. Expression of epidermal growth factor receptor messenger RNA in human colorectal carcinomas assessed by non-radioactive in situ hybridization
20. Level and function of epidermal growth factor predict the metastatic potential of human colon carcinoma cells
21. Paracrine growth regulation of human colon carcinoma organ-specific metastasis
22. Expression of several growth factors and their receptor genes in human colon carcinomas
23. The expression of p185 HER-2/neu correlates with the stage of disease and survival in colorectal cancer
24. Biochemical mechanisms of tumor invasion and metastases
25. Metalloproteinases and cancer invasion
26. Matrix metalloproteinases in tumour invasion and metastasis
27. Augmentation of type IV collagenase and laminin receptors immunoreactivity associated with human breast, colon and gastric carcinoma progression
28. Gelatinase A (MMP-2) and its mRNA detected in both neoplastic and stromal cells of tumors with different invasive and metastatic properties
29. Prognosis of gastric carcinoma revealed by interactions between tumor cells and basement membrane
30. Increased expression of the 72 kDa type IV collagenase in human colonic adenocarcinoma
31. Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia
32. Expression of insulin-like growth factor-2 can predict the prognosis of human colorectal cancer patients: Correlation with tumor progression, proliferative activity and survival
33. Tissue-specific expression pattern of vascular endothelial growth factor isoforms in the malignant transformation of lung and colon
34. Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer
35. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation of human colon cancer
36. Tumor angiogenesis predicts recurrence in invasive colorectal cancer when controlled for Dukes staging
37. Tumor angiogenesis and mode of metastasis in patients with colorectal cancer
38. Tumor angiogenesis as a prognostic predictor in colorectal carcinoma with special reference to mode of metastasis and recurrence
39. Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer
40. Quantification of angiogenesis in solid human tumours: An international consensus on the methodology and criteria of evaluation
41. Angiogenesis in breast cancer: A comparative study on the observer variability of methods for determining microvessel density
42. Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count and computer image analysis
43. An improved procedure to quantify tumour vascularity using true colour image analysis. Comparison with the manual hot-spot procedure in a human melanoma xenograft model
44. Significance of angiogenic factors in liver metastatic tumors originating from colorectal cancers
45. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis
46. Protein markers in colorectal cancer: Predictors of liver metastasis
47. Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients
48. Angiogenesis as a predictor of clinical outcome in cancer patients
49. Angiogenesis in colorectal tumors: Microvessel quantitation in adenomas and carcinomas with clinicopathological correlations
50. The prognostic significance of tumor vascularization in patients with localized colorectal cancer
51. Relationship between microvessel quantification and inducibility of endogenous tumor necrosis factor in colorectal adenocarcinoma
52. Vasculogenic mimicry and tumor angiogenesis
53. Matrix metalloproteinases: Biologic activity and clinical implications
54. SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors
55. Vascular endothelial growth factor in human colon cancer: Biology and therapeutic implications
56. Antagonistic analogs of growth hormone-releasing hormone: New potential antitumor agents
57. Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers
58. Increased type IV collagen-degrading activity in metastases originating from primary tumors of the human colon
59. Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer
60. Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: A comparison with clinically used tumor markers
61. Matrix metalloproteinase 2 immunoreactive protein appears early in cervical dedifferentiation
62. Sequential activation and production of matrix metalloproteinase-2 during breast cancer progression
63. Tumor angiogenesis in primary and metastatic colorectal cancers
64. Morphological aspects of angiogenesis in experimental liver metastasis